Investing in TRx Biosciences
The TRx Leadership Team have exceptional track records in creating value for shareholders and completing transactions. This team is driving TRx through a series of inflection points as the company enters the following growth phases:
- Pre-clinical Pipeline Validation - Funded and Work On-going
- Early Clinical Proof-of-Concept - Fundraising in H2 2022
- Patient proof-of-concept - Fundraising in H2 2023
TRx is keen to hear from investors interested in joining our progressive journey as TRx delivers on its promise of creating a step-change in the biodistribution of small molecule drugs.